CGP 3466 protects dopaminergic neurons in lesion models of Parkinson's disease. [electronic resource]
Producer: 20010222Description: 526-37 p. digitalISSN:- 0028-1298
- 1-Methyl-4-phenylpyridinium -- toxicity
- Animals
- Antiparkinson Agents -- pharmacology
- Brain -- drug effects
- Cell Culture Techniques
- Cell Death -- drug effects
- Disease Models, Animal
- Dopamine -- metabolism
- Female
- Liver -- drug effects
- Mesencephalon -- cytology
- Mice
- Mice, Inbred C57BL
- Monoamine Oxidase -- metabolism
- Monoamine Oxidase Inhibitors -- pharmacology
- Neurons -- drug effects
- Oxepins -- pharmacology
- Oxidopamine
- Parkinsonian Disorders -- drug therapy
- Pregnancy
- Rats
- Selegiline -- pharmacology
- Substantia Nigra -- enzymology
- Tritium
- Tyrosine 3-Monooxygenase -- metabolism
No physical items for this record
Publication Type: Comparative Study; Journal Article
There are no comments on this title.
Log in to your account to post a comment.